Bio-Rad Laboratories Class A
508 hedge funds and large institutions have $12.4B invested in Bio-Rad Laboratories Class A in 2021 Q2 according to their latest regulatory filings, with 61 funds opening new positions, 193 increasing their positions, 172 reducing their positions, and 41 closing their positions.
49% more first-time investments, than exits
New positions opened: 61 | Existing positions closed: 41
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more repeat investments, than reductions
Existing positions increased: 193 | Existing positions reduced: 172
11% more capital invested
Capital invested by funds: $11.2B → $12.4B (+$1.18B)
3% more funds holding
Funds holding: 491 → 508 (+17)
0.61% less ownership
Funds ownership: 79.25% → 78.65% (-0.61%)
49% less call options, than puts
Call options by funds: $39.6M | Put options by funds: $78.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$66.6M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$59.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.7M |
| 4 |
Bank of New York Mellon
New York
|
+$39.8M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$35.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$246M |
| 2 |
N
Natixis
Paris,
France
|
-$87.8M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$81.4M |
| 4 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$72.1M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$67.2M |
BIO Hedge Fund Activity: Q2 2021 in Review
508 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2021, worth a combined $12.4B — up 11% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 61 funds opened new BIO positions and 41 closed out — a net gain of 20 holders — while 193 added to existing stakes and 172 trimmed.
The largest buyer was Franklin Resources, adding an estimated $66.6M. The largest seller was American Century Companies, cutting an estimated $246M.
- 508 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2021, up from 491 in Q1 2021.
- Funds reported $12.4B of Bio-Rad Laboratories Class A stock for Q2 2021, up 11% quarter-over-quarter.
- 61 funds opened new Bio-Rad Laboratories Class A positions in Q2 2021 and 41 closed out, a net change of +20 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q2 2021 was Franklin Resources, an estimated $66.6M added.
- The largest Bio-Rad Laboratories Class A seller in Q2 2021 was American Century Companies, an estimated $246M sold.
Based on aggregated 13F filings for Q2 2021.